Mounting Evidence of Vaccine Harms, Lack of Safety Studies, and the Need for Independent Research
I am writing to you as a concerned citizen and parent who has spent years compiling peer-reviewed evidence on the risks associated with childhood vaccines. The explosion in chronic childhood illnesses, from autism spectrum disorder (ASD) rates climbing to 1 in 31 children aged 8 (a staggering increase from 1 in 150 just two decades ago) to over 50% of U.S. children now suffering from at least one chronic condition, demands immediate scrutiny. Before 1986, children received roughly 11 vaccine doses (7 injections and 4 oral) for a handful of diseases; today, the CDC schedule mandates up to 72 doses by age 18, correlating with this health crisis. Yet, vaccine manufacturers enjoy blanket liability protection under the 1986 National Childhood Vaccine Injury Act (NCVIA), which shields them from civil lawsuits for injuries or deaths, funneling claims into a no-fault system that’s paid out over $5.2 billion to nearly 10,000 victims—taxpayer-funded, with underreporting rampant (only ~1% of cases captured).
I’ve compiled irrefutable evidence from PubMed studies, government admissions, and expert analyses showing vaccines’ role in neurodevelopmental harms like autism, the absence of rigorous safety testing, and systemic misleading by authorities. I urge you to review this data, conduct or fund truly independent research (e.g., double-blind, placebo-controlled trials on the full schedule), and advocate for repealing the NCVIA’s liability shield—restoring accountability so manufacturers prioritize safety over profits. Our children deserve better than “unavoidably unsafe” products foisted on them without consent.
1. Vaccines and Autism: Overwhelming Evidence from Peer-Reviewed Studies
Dozens of studies link vaccines—via thimerosal (mercury), aluminum adjuvants, MMR antigens, and cumulative overload—to ASD. Here’s a fraction (full list with DOIs below):
- A two-phase study on thimerosal exposure found children receiving higher doses from hepatitis B and DTaP vaccines had up to 3.39 times higher odds of ASD diagnosis in their first six months. PMC3878266
- State-level analysis: A 1% increase in vaccination coverage by age two correlates with 680 additional autism or speech impairment cases annually. PubMed 21623535
- MMR antibodies: 125 autistic children showed 83% elevated measles-specific responses and 90% overlap with myelin basic protein autoantibodies, suggesting vaccine-triggered CNS autoimmunity. PubMed 12145534
- Mercury encephalopathy: Regressive autism cases scaled with thimerosal dose; chelation reduced symptoms. PubMed 17454560
- Subtle DNA changes and overuse of vaccines in autism: Genetic alterations from environmental toxins like vaccine adjuvants may predispose to ASD. PMC3364648
- Causal relationship between vaccine-induced immunity and autism: Immune dysregulation post-vaccination linked to neurodevelopment. PubMed 12849883
- Elevated measles levels in ASD children: Abnormal antibody response to MMR. PubMed 12849883
- Relation of mercury to high autism rates in boys: Boys’ vulnerability to thimerosal. PubMed 16264412
- Tylenol post-MMR and autism: Parent survey shows increased risk. PubMed 18445737
- Fetal cell contamination with retrovirus: Human fetal DNA in vaccines tied to ASD and cancer. Global Research; Deisher PDF
- Hypothesis: Conjugate vaccines predispose to ASD. PubMed 21993250
- Rise in autism coincides with rise in vaccines: Temporal correlation. PubMed 21623535
These aren’t fringe; they’re government-indexed. Yet, CDC claims “no link”—despite whistleblower William Thompson exposing data manipulation in the 2004 MMR study (10,000 docs to Sen. Posey). Recent 2023-2025 reviews (e.g., WHO ’25 statement, Johns Hopkins ’25) reaffirm no causal tie, but overlook these correlations and call for more research amid ongoing debates. I request you investigate these studies and fund replications without conflicts.
2. No Double-Blind, Placebo-Controlled Studies: A Glaring Safety Gap
The entire CDC schedule lacks true safety testing—no randomized, double-blind trials using inert saline placebos. ICAN’s 2017 analysis reviewed FDA/CDC approvals: Zero such studies for any routine childhood vaccine from 1986-2017; most use another vaccine or adjuvant as “placebo,” skewing results. HHS stipulated in 2018: No “adequate and well-controlled” investigations in 32 years, violating the Act’s mandates. ICAN White Paper; HHS Stipulation.
This isn’t oversight—it’s systemic. Recent admissions amplify the crisis: In 2024, “godfather of vaccinology” Dr. Stanley Plotkin co-authored a NEJM paper conceding prelicensure trials are “inadequate” for safety due to small samples, short follow-ups, and limited diversity—contradicting decades of “thoroughly studied” claims. Post-auth studies are “needed to fully characterize” risks, yet funding lags. ICAN’s 2023 FOIAs exposed CDC/NIH lacking even one study on aluminum adjuvant safety in kids, despite its neurotoxicity in 5+ vaccines. 2025 saw HHS revive the Task Force on Safer Childhood Vaccines (Aug), spurred by RFK Jr., to probe these gaps—but ethicists decry “pyramid schemes” like MenQuadfi’s 2025 infant approval (5.3% serious AEs vs. another vax, no placebo), circularly basing safety on unproven priors. ACIP’s June 2025 meeting saw pushback on CDC’s “robust surveillance” for COVID shots, demanding RCTs to curb biases. Fool’s-gold science: US HHS’s 2025 proposal for placebo trials on new vaccines highlights the ethical perils of skipping them, as seen in past oversights. RFK Jr.’s ’25 push: All new vaccines must face placebos, per PBS reports. How can we trust “safe and effective” without gold-standard evidence? Demand: Immediate RCTs on the full schedule, inert placebos mandatory.
3. Misleading Information from Authorities
CDC routinely downplays risks: E.g., 2025 pregnancy vax guidance ignores miscarriage signals (OR 1.45 first trimester); autism “myths” debunk ignores the 30+ studies above. Fact-checks label critics “misinfo,” yet VICP payouts prove harms real. CDC Myths (via NYT ’25).
Further examples: CDC’s 2024 autism FAQ affirms “no link” to vaccines, citing 9 CDC-funded studies since 2003 dismissing thimerosal/MMR ties—yet ignores whistleblower claims of data fraud and 2025 political pressure for reexamination (NBC: CDC to probe despite “debunked”). WHO’s Sep ’25 statement: “No conclusive evidence” of vax-autism link, but admits ongoing scrutiny amid parental concerns. IDSA’s ’25 endorsement of CDC studies: “Decades of research” show no association, overlooking correlations in PubMeds above. Politifact ’21 (updated ’25): Debunks 1986 Act as cause of schedule jump, but concedes payouts reflect real harms. Transparency now—release raw data, address fraud allegations.
4. The 1986 Vaccine Act: Immunity for Harm
NCVIA created VICP to “stabilize supply” amid lawsuits, granting manufacturers total civil immunity for design defects or failures—claims go to a kangaroo court (DOJ/HHS), with 60% settlements, no admission of fault. Pre-Act: 3 doses by age 6; post: 50+ by 2, exploding to 72 by 18—paralleling ASD from 1/10,000 to 1/31, allergies 1/10 kids, ADHD 1/10. Kids are sicker—why no liability? Repeal it; make them answer in court. Full Act; SCOTUS Ruling.
Impacts: Wikipedia/HRSA: Act eliminated financial liability, leading to market stability and schedule expansion (e.g., Hep B ’91, varicella ’95, pneumo ’00)—doses tripled by 2000, sextupled by 2025. IOM/NCBI: Pre-Act shortages from suits; post: Innovation surged, but safety lagged (no incentive). PhRMA ’25: VICP “fair,” but critics (HistoryOfVaccines) note under-compensation (e.g., $500M+ MMR payouts alone, per HRSA data). UCA study: Act correlated with chronic illness rise. Kids are sicker—why no liability? Repeal it; make them answer in court.
5. The Absurdity of the Newborn Hepatitis B Vaccine
Why jab every healthy newborn for a sexually transmitted/lifestyle disease (Hep B)? Transmission risk <1% in U.S. infants (mostly maternal); yet, it’s mandated day 1—despite aluminum load 75x safe for 7lb babies (0.5mg/dose vs. 0.006mg limit), potential demyelination/MS links, and no long-term placebo trials. Benefits? 99% drop in pediatric cases, but critics note overkill for low-risk (STD proxy), ignoring anaphylaxis (1/600k) and chronic risks. Delay to adolescence? Critique; NCBI Review.
Who gets Hep B? Primarily adults via sexual contact (unprotected/multiple partners), IV drug use (shared needles), or occupational exposure (healthcare workers). Perinatal: 90% chronic if infected at birth, but U.S. mom-to-baby rate <2% with screening/treatment. Non-perinatal infant risk: <0.3% household/accidental. CDC: Mild side effects (pain, fatigue); 98% seroprotection. But PMC: Preterm safety lacking; PubMed: High chronic carriage inverse to age, but universal dose reduces carriage more than targeted. 2025 ACIP: Debate delay if mom negative, citing low risk (KFF poll: 9% skip). Breastfeeding negligible if vaxxed. Overkill exposes to toxins without need.
In closing, this isn’t anti-science. It’s pro-truth. With $5.2B in acknowledged injuries, no liability, and zero full-schedule studies, how can we trust? Please: Commission independent research, push NCVIA reform, and prioritize kids’ health over mandates. I’m happy to discuss or provide more data.
6. HPV Vaccine
The HPV vaccine, like Gardasil, packs a unique punch with its adjuvant called amorphous aluminum hydroxyphosphate sulfate (AAHS)—a proprietary Merck formulation that is chemically and biologically distinct from the basic aluminum hydroxide or aluminum phosphate used in older vaccines. This isn’t a small tweak; it’s a new molecular entity with different surface area, charge, reactivity, and bio-distribution characteristics, yet it bypassed traditional toxicology pathways because regulators treat all “aluminum adjuvants” as interchangeable. Per the FDA package insert, each Gardasil 9 dose adsorbs its virus-like particles (VLPs) onto this AAHS scaffold, delivering 225 micrograms of aluminum per shot (FDA, 2020). But here’s the kicker: AAHS has been shown to behave nothing like legacy aluminum salts.
Instead of dissolving and clearing quickly through the kidneys, AAHS persists, resisting breakdown and engaging the immune system in ways neither regulators nor clinicians have fully grappled with. As documented in biodistribution studies, macrophages engulf the AAHS aggregates at the injection site and carry them throughout the lymphatic network, ultimately depositing aluminum in long-term biological reservoirs — muscle, lymph nodes, spleen, and, most concerning, the central nervous system (Khan et al., 2013, Frontiers in Neurology). This macrophage-mediated “Trojan horse” transport explains why aluminum deposits have been detected months to years post-vaccination, long after blood levels return to baseline.
This biopersistence isn’t theoretical; it’s the defining pathology of macrophagic myofasciitis (MMF), a condition identified in muscle biopsies showing crystalline aluminum-laden macrophages, chronic immune activation, myalgia, and neurocognitive symptoms. Research by Gherardi and colleagues (2015, Lupus) demonstrates that aluminum adjuvants — especially poorly biodegradable forms like AAHS, can trigger a cascading inflammatory response, dysregulate cytokine networks, and prime microglia in the brain, creating a vulnerability to long-term autoimmune and neurological dysfunction. In other words: this is not your grandfather’s adjuvant. It’s a slow-release, body-wide inflammatory stimulus with persistence and potency that were never properly evaluated in pre-licensure trials.
When HPV vaccine safety claims lump AAHS together with generic “aluminum,” they blur a critical scientific distinction. Merck introduced a novel, more reactive aluminum compound, used it in a vaccine given to preteens, yet the adjuvant itself has no standalone chronic toxicity studies, no long-term biodistribution trials, and no inert-placebo comparisons. That gap matters, because AAHS’s durability and transport behavior raise real concerns about autoimmunity, neuroinflammation, and cumulative load—risks that regulators simply assumed away. This slow-burn aluminum trafficking is not alarmism; it’s a documented mechanism demanding a level of scrutiny that, to date, has never occurred.
References Appendix Vaccines and Autism: Peer-Reviewed Studies (PubMed/PMC Links)
- Thimerosal two-phase study: PMC3878266
- Vaccination uptake correlation: PubMed 21623535
- MMR antibodies/autoimmunity: PubMed 12145534
- Mercury encephalopathy: PubMed 17454560
- Additional studies: PubMed 25377033 | 24995277 | 21058170 | 22099159 | PMC3364648 | 19106436 | PMC3774468 | PMC3697751 | 21299355 | 21907498 | 11339848 | 17674242 | 21993250 | 15780490 | 12933322 | 16870260 | 19043938 | 12142947 | 24675092 | 9345669 | 18086216 | 24238833 | 25198681
Safety Testing Gaps
- ICAN White Paper (No Placebos): ICAN White Paper
- HHS Stipulation (32 Years No Studies): HHS Stipulation
Misleading Info & CDC Claims
- CDC Myths Debunk (via Mayo/NYT 2025): Mayo Clinic Myths
- Pregnancy Miscarriage Signal: MedScienceResearch Fetal Death
Negative CNS Impacts of Aluminum in Vaccines and Immunotherapy
https://pubmed.ncbi.nlm.nih.gov/25428645
1986 Act & Liability
- Full NCVIA Text: Congress.gov Bill
- SCOTUS “Unavoidably Unsafe” Ruling (Bruesewitz v. Wyeth): Supreme Court PDF
- VICP Payouts ($5.2B+ as of Oct 2025): HRSA Data
- Injury Table: HRSA Table
Hepatitis B Vaccine Critique
- Risks vs. Benefits (Contemporary Pediatrics): Contemporary Pediatrics Article
- NCBI Review (Demyelination/MS Links): NCBI Book
- Aluminum Load Critique: ATSDR Tox Guide
- Anaphylaxis Rate: CDC Pink Book
General Resources
- VAERS Reporting: VAERS.hhs.gov
- CDC Whistleblower (Thompson): Morgan Verkamp Statement
- Chronic Illness Stats: Fearless Parent
IF YOU VACCINE During the first 6 years of life, your child will get the following:
Vaccines and allergies
VACCINATION EDUCATION
Information and ingredients related:
Inserts:
Video from Dr. Palevsky on ingredients:
Materials Safety Data Sheets:
Vaccine package inserts:
Here is the fastest way to shut down vaccine science:
Back to how vaccines work..
So what does this mean?
Polysorbate 80
Vaccines and Autism
IMPORTANT
Fetal Cells & Vaccine Contaminates
Vaccine Failure & Shedding
Stories
SIDS
COVID
1-Year Risks of Cancers associated with Covid-19 vaccination

